Skip to main content
NCBI home page
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 1989 Jul;33(7):995–999. doi: 10.1128/aac.33.7.995

Methicillin-resistant staphylococci: detection methods and treatment of infections.

C J Hackbarth 1, H F Chambers 1
PMCID: PMC176051  PMID: 2675760

Full text

PDF
995

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Aldridge K. E., Janney A., Sanders C. V. Comparison of the activities of coumermycin, ciprofloxacin, teicoplanin, and other non-beta-lactam antibiotics against clinical isolates of methicillin-resistant Staphylococcus aureus from various geographical locations. Antimicrob Agents Chemother. 1985 Nov;28(5):634–638. doi: 10.1128/aac.28.5.634. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Aldridge K. E., Janney A., Sanders C. V., Marier R. L. Interlaboratory variation of antibiograms of methicillin-resistant and methicillin-susceptible Staphylococcus aureus strains with conventional and commercial testing systems. J Clin Microbiol. 1983 Nov;18(5):1226–1236. doi: 10.1128/jcm.18.5.1226-1236.1983. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Annear D. I. The effect of temperature on resistance of Staphylococcus aureus to methicillin and some other antibioics. Med J Aust. 1968 Mar 16;1(11):444–446. [PubMed] [Google Scholar]
  4. Archer G. L., Vazquez G. J., Johnston J. L. Antibiotic prophylaxis of experimental endocarditis due to methicillin-resistant Staphylococcus epidermidis. J Infect Dis. 1980 Nov;142(5):725–731. doi: 10.1093/infdis/142.5.725. [DOI] [PubMed] [Google Scholar]
  5. BARBER M. Methicillin-resistant staphylococci. J Clin Pathol. 1961 Jul;14:385–393. doi: 10.1136/jcp.14.4.385. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. BARBER M. NATURALLY OCCURING METHICILLIN-RESISTANT STAPHYLOCOCCI. J Gen Microbiol. 1964 May;35:183–190. doi: 10.1099/00221287-35-2-183. [DOI] [PubMed] [Google Scholar]
  7. Barna J. C., Williams D. H. The structure and mode of action of glycopeptide antibiotics of the vancomycin group. Annu Rev Microbiol. 1984;38:339–357. doi: 10.1146/annurev.mi.38.100184.002011. [DOI] [PubMed] [Google Scholar]
  8. Barrett F. F., McGehee R. F., Jr, Finland M. Methicillin-resistant Staphylococcus aureus at Boston City Hospital. Bacteriologic and epidemiologic observations. N Engl J Med. 1968 Aug 29;279(9):441–448. doi: 10.1056/NEJM196808292790901. [DOI] [PubMed] [Google Scholar]
  9. Barry A. L., Badal R. E. Reliability of the microdilution technic for detection of methicillin-resistant strains of staphylococcus aureus. Am J Clin Pathol. 1977 May;67(5):489–495. doi: 10.1093/ajcp/67.5.489. [DOI] [PubMed] [Google Scholar]
  10. Berry A. J., Johnston J. L., Archer G. L. Imipenem therapy of experimental Staphylococcus epidermidis endocarditis. Antimicrob Agents Chemother. 1986 May;29(5):748–752. doi: 10.1128/aac.29.5.748. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Bibler M. R., Frame P. T., Hagler D. N., Bode R. B., Staneck J. L., Thamlikitkul V., Harris J. E., Haregewoin A., Bullock W. E., Jr Clinical evaluation of efficacy, pharmacokinetics, and safety of teicoplanin for serious gram-positive infections. Antimicrob Agents Chemother. 1987 Feb;31(2):207–212. doi: 10.1128/aac.31.2.207. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Boyce J. M. Reevaluation of the ability of the standardized disk diffusion test to detect methicillin-resistant strains of Staphylococcus aureus. J Clin Microbiol. 1984 Jun;19(6):813–817. doi: 10.1128/jcm.19.6.813-817.1984. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Boyce J. M., White R. L., Bonner M. C., Lockwood W. R. Reliability of the MS-2 system in detecting methicillin-resistant Staphylococcus aureus. J Clin Microbiol. 1982 Feb;15(2):220–225. doi: 10.1128/jcm.15.2.220-225.1982. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. CALLAGHAN R. P., COHEN S. J., STEWART G. T. Septicaemia due to colonization of Spitz-Holter valves by staphylococci. Five cases treated with methicillin. Br Med J. 1961 Mar 25;1(5229):860–863. doi: 10.1136/bmj.1.5229.860. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Calain P., Krause K. H., Vaudaux P., Auckenthaler R., Lew D., Waldvogel F., Hirschel B. Early termination of a prospective, randomized trial comparing teicoplanin and flucloxacillin for treating severe staphylococcal infections. J Infect Dis. 1987 Feb;155(2):187–191. doi: 10.1093/infdis/155.2.187. [DOI] [PubMed] [Google Scholar]
  16. Carlson J. R., Conley F. E., Cahall D. L. Methicillin-resistant Staphylococcus aureus susceptibility testing with Abbott MS-2 system. Antimicrob Agents Chemother. 1982 Apr;21(4):676–677. doi: 10.1128/aac.21.4.676. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Carpenter T. C., Hackbarth C. J., Chambers H. F., Sande M. A. Efficacy of ciprofloxacin for experimental endocarditis caused by methicillin-susceptible or -resistant strains of Staphylococcus aureus. Antimicrob Agents Chemother. 1986 Sep;30(3):382–384. doi: 10.1128/aac.30.3.382. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Chambers H. F., Hackbarth C. J., Drake T. A., Rusnak M. G., Sande M. A. Endocarditis due to methicillin-resistant Staphylococcus aureus in rabbits: expression of resistance to beta-lactam antibiotics in vivo and in vitro. J Infect Dis. 1984 Jun;149(6):894–903. doi: 10.1093/infdis/149.6.894. [DOI] [PubMed] [Google Scholar]
  19. Chambers H. F., Hackbarth C. J. Effect of NaCl and nafcillin on penicillin-binding protein 2a and heterogeneous expression of methicillin resistance in Staphylococcus aureus. Antimicrob Agents Chemother. 1987 Dec;31(12):1982–1988. doi: 10.1128/aac.31.12.1982. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Chambers H. F. Methicillin-resistant staphylococci. Clin Microbiol Rev. 1988 Apr;1(2):173–186. doi: 10.1128/cmr.1.2.173. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Chambers H. F., Sande M. A. Teicoplanin versus nafcillin and vancomycin in the treatment of experimental endocarditis caused by methicillin-susceptible or -resistant Staphylococcus aureus. Antimicrob Agents Chemother. 1984 Jul;26(1):61–64. doi: 10.1128/aac.26.1.61. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Coles N. W., Gross R. Liberation of surface-located penicillinase from Staphylococcus aureus. Biochem J. 1967 Mar;102(3):742–747. doi: 10.1042/bj1020742. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Coudron P. E., Jones D. L., Dalton H. P., Archer G. L. Evaluation of laboratory tests for detection of methicillin-resistant Staphylococcus aureus and Staphylococcus epidermidis. J Clin Microbiol. 1986 Nov;24(5):764–769. doi: 10.1128/jcm.24.5.764-769.1986. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Crossley K., Loesch D., Landesman B., Mead K., Chern M., Strate R. An outbreak of infections caused by strains of Staphylococcus aureus resistant to methicillin and aminoglycosides. I. Clinical studies. J Infect Dis. 1979 Mar;139(3):273–279. doi: 10.1093/infdis/139.3.273. [DOI] [PubMed] [Google Scholar]
  25. DOWLING H. F. The newer penicillins. Clin Pharmacol Ther. 1961 Sep-Oct;2:572–580. doi: 10.1002/cpt196125572. [DOI] [PubMed] [Google Scholar]
  26. Dillon L. K., Howe S. E. Early detection of oxacillin-resistant staphylococcal strains with hypertonic broth diluent for microdilution panels. J Clin Microbiol. 1984 Apr;19(4):473–476. doi: 10.1128/jcm.19.4.473-476.1984. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Drew W. L., Barry A. L., O'Toole R., Sherris J. C. Reliability of the Kirby-Bauer disc diffusion method for detecting methicillin-resistant strains of Staphylococcus aureus. Appl Microbiol. 1972 Aug;24(2):240–247. doi: 10.1128/am.24.2.240-247.1972. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Dyke K. G. Penicillinase production and intrinsic resistance to penicillins in methicillin-resistant cultures of Staphylococcus aureus. J Med Microbiol. 1969 Aug;2(3):261–278. doi: 10.1099/00222615-2-3-261. [DOI] [PubMed] [Google Scholar]
  29. Eliopoulos G. M., Willey S., Reiszner E., Spitzer P. G., Caputo G., Moellering R. C., Jr In vitro and in vivo activity of LY 146032, a new cyclic lipopeptide antibiotic. Antimicrob Agents Chemother. 1986 Oct;30(4):532–535. doi: 10.1128/aac.30.4.532. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Elwell L. P., Wilson H. R., Knick V. B., Keith B. R. In vitro and in vivo efficacy of the combination trimethoprim-sulfamethoxazole against clinical isolates of methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother. 1986 Jun;29(6):1092–1094. doi: 10.1128/aac.29.6.1092. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Fan W., del Busto R., Love M., Markowitz N., Cendrowski C., Cardenas J., Quinn E., Saravolatz L. Imipenem-cilastatin in the treatment of methicillin-sensitive and methicillin-resistant Staphylococcus aureus infections. Antimicrob Agents Chemother. 1986 Jan;29(1):26–29. doi: 10.1128/aac.29.1.26. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Fass R. J., Helsel V. L., Barnishan J., Ayers L. W. In vitro susceptibilities of four species of coagulase-negative staphylococci. Antimicrob Agents Chemother. 1986 Oct;30(4):545–552. doi: 10.1128/aac.30.4.545. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Faville R. J., Jr, Zaske D. E., Kaplan E. L., Crossley K., Sabath L. D., Quie P. G. Staphylococcus aureus endocarditis. Combined therapy with vancomycin and rifampin. JAMA. 1978 Oct 27;240(18):1963–1965. doi: 10.1001/jama.240.18.1963. [DOI] [PubMed] [Google Scholar]
  34. Frame P. T., McLaurin R. L. Treatment of CSF shunt infections with intrashunt plus oral antibiotic therapy. J Neurosurg. 1984 Feb;60(2):354–360. doi: 10.3171/jns.1984.60.2.0354. [DOI] [PubMed] [Google Scholar]
  35. Frongillo R. F., Bianchi P., Moretti A., Pasticci M. B., Ripa S., Pauluzzi S. Cross-resistance between methicillin and cephalosporins for staphylococci: a general assumption not true for cefamandole. Antimicrob Agents Chemother. 1984 May;25(5):666–668. doi: 10.1128/aac.25.5.666. [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. Frongillo R. F., Donati L., Federico G., Martino P., Moroni M., Ortona L., Palumbo M., Pasticci B. M., Pizzigallo E., Privitera G. Clinical comparative study on the activity of cefamandole in the treatment of serious staphylococcal infections caused by methicillin-susceptible and methicillin-resistant strains. Antimicrob Agents Chemother. 1986 May;29(5):789–796. doi: 10.1128/aac.29.5.789. [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. Glupczynski Y., Lagast H., Van der Auwera P., Thys J. P., Crokaert F., Yourassowsky E., Meunier-Carpentier F., Klastersky J., Kains J. P., Serruys-Schoutens E. Clinical evaluation of teicoplanin for therapy of severe infections caused by gram-positive bacteria. Antimicrob Agents Chemother. 1986 Jan;29(1):52–57. doi: 10.1128/aac.29.1.52. [DOI] [PMC free article] [PubMed] [Google Scholar]
  38. Gopal V., Bisno A. L., Silverblatt F. J. Failure of vancomycin treatment in Staphylococcus aureus endocarditis. In vivo and in vitro observations. JAMA. 1976 Oct 4;236(14):1604–1606. [PubMed] [Google Scholar]
  39. Greenberg R. N., Kennedy D. J., Reilly P. M., Luppen K. L., Weinandt W. J., Bollinger M. R., Aguirre F., Kodesch F., Saeed A. M. Treatment of bone, joint, and soft-tissue infections with oral ciprofloxacin. Antimicrob Agents Chemother. 1987 Feb;31(2):151–155. doi: 10.1128/aac.31.2.151. [DOI] [PMC free article] [PubMed] [Google Scholar]
  40. Hackbarth C. J., Chambers H. F., Sande M. A. Serum bactericidal activity of rifampin in combination with other antimicrobial agents against Staphylococcus aureus. Antimicrob Agents Chemother. 1986 Apr;29(4):611–613. doi: 10.1128/aac.29.4.611. [DOI] [PMC free article] [PubMed] [Google Scholar]
  41. Hansen S. L., Freedy P. K. Variation in the abilities of automated, commercial, and reference methods to detect methicillin-resistant (heteroresistant) Staphylococcus aureus. J Clin Microbiol. 1984 Sep;20(3):494–499. doi: 10.1128/jcm.20.3.494-499.1984. [DOI] [PMC free article] [PubMed] [Google Scholar]
  42. Hartman B. J., Tomasz A. Expression of methicillin resistance in heterogeneous strains of Staphylococcus aureus. Antimicrob Agents Chemother. 1986 Jan;29(1):85–92. doi: 10.1128/aac.29.1.85. [DOI] [PMC free article] [PubMed] [Google Scholar]
  43. Hindler J. A., Warner N. L. Effect of source of Mueller-Hinton agar on detection of oxacillin resistance in Staphylococcus aureus using a screening methodology. J Clin Microbiol. 1987 Apr;25(4):734–735. doi: 10.1128/jcm.25.4.734-735.1987. [DOI] [PMC free article] [PubMed] [Google Scholar]
  44. Hooper D. C., Wolfson J. S., McHugh G. L., Winters M. B., Swartz M. N. Effects of novobiocin, coumermycin A1, clorobiocin, and their analogs on Escherichia coli DNA gyrase and bacterial growth. Antimicrob Agents Chemother. 1982 Oct;22(4):662–671. doi: 10.1128/aac.22.4.662. [DOI] [PMC free article] [PubMed] [Google Scholar]
  45. JORDAN D. C. EFFECT OF VANCOMYCIN ON THE SYNTHESIS OF THE CELL WALL AND CYTOPLASMIC MEMBRANE OF STAPHYLOCOCCUS AUREUS. Can J Microbiol. 1965 Apr;11:390–393. doi: 10.1139/m65-050. [DOI] [PubMed] [Google Scholar]
  46. JORDAN D. C., INNISS W. E. Selective inhibition of ribonucleic acid synthesis in Staphylococcus aureus by vancomycin. Nature. 1959 Dec 12;184(Suppl 24):1894–1895. doi: 10.1038/1841894b0. [DOI] [PubMed] [Google Scholar]
  47. Kim T. K., Chipley J. R. Effect of salts on penicillinase release by Staphylococcus aureus. Microbios. 1974 Jun-Jul;10A SUPPL(41):55–63. [PubMed] [Google Scholar]
  48. Klimek J. J., Marsik F. J., Bartlett R. C., Weir B., Shea P., Quintiliani R. Clinical, epidemiologic and bacteriologic observations of an outbreak of methicillin-resistant Staphylococcus aureus at a large community hospital. Am J Med. 1976 Sep;61(3):340–345. doi: 10.1016/0002-9343(76)90370-3. [DOI] [PubMed] [Google Scholar]
  49. Knapp C. C., Washington J. A., 2nd Antistaphylococcal activity of a cyclic peptide, LY146032, and vancomycin. Antimicrob Agents Chemother. 1986 Dec;30(6):938–939. doi: 10.1128/aac.30.6.938. [DOI] [PMC free article] [PubMed] [Google Scholar]
  50. Mandell G. L., Moorman D. R. Treatment of experimental staphylococcal infections: effect of rifampin alone and in combination on development of rifampin resistance. Antimicrob Agents Chemother. 1980 Apr;17(4):658–662. doi: 10.1128/aac.17.4.658. [DOI] [PMC free article] [PubMed] [Google Scholar]
  51. Mandell G. L., Vest T. K. Killing of intraleukocytic Staphylococcus aureus by rifampin: in-vitro and in-vivo studies. J Infect Dis. 1972 May;125(5):486–490. doi: 10.1093/infdis/125.5.486. [DOI] [PubMed] [Google Scholar]
  52. Massanari R. M., Donta S. T. The efficacy of rifampin as adjunctive therapy in selected cases of staphylococcal endocarditis. Chest. 1978 Mar;73(3):371–375. doi: 10.1378/chest.73.3.371. [DOI] [PubMed] [Google Scholar]
  53. McDougal L. K., Thornsberry C. The role of beta-lactamase in staphylococcal resistance to penicillinase-resistant penicillins and cephalosporins. J Clin Microbiol. 1986 May;23(5):832–839. doi: 10.1128/jcm.23.5.832-839.1986. [DOI] [PMC free article] [PubMed] [Google Scholar]
  54. Myers J. P., Linnemann C. C., Jr Bacteremia due to methicillin-resistant Staphylococcus aureus. J Infect Dis. 1982 Apr;145(4):532–536. doi: 10.1093/infdis/145.4.532. [DOI] [PubMed] [Google Scholar]
  55. Neu H. C., Chin N. X., Neu N. M. In vitro activity and beta-lactamase stability of a new penem, CGP 31608. Antimicrob Agents Chemother. 1987 Apr;31(4):558–569. doi: 10.1128/aac.31.4.558. [DOI] [PMC free article] [PubMed] [Google Scholar]
  56. Nieto M., Perkins H. R. Modifications of the acyl-D-alanyl-D-alanine terminus affecting complex-formation with vancomycin. Biochem J. 1971 Aug;123(5):789–803. doi: 10.1042/bj1230789. [DOI] [PMC free article] [PubMed] [Google Scholar]
  57. Nieto M., Perkins H. R. Physicochemical properties of vancomycin and iodovancomycin and their complexes with diacetyl-L-lysyl-D-alanyl-D-alanine. Biochem J. 1971 Aug;123(5):773–787. doi: 10.1042/bj1230773. [DOI] [PMC free article] [PubMed] [Google Scholar]
  58. Nieto M., Perkins H. R. The specificity of combination between ristocetins and peptides related to bacterial cell wall mucopeptide precursors. Biochem J. 1971 Oct;124(5):845–852. doi: 10.1042/bj1240845. [DOI] [PMC free article] [PubMed] [Google Scholar]
  59. Pattison J. R., Mansell P. E. Fucidin-resistant staphylococci in current hospital practice. J Med Microbiol. 1973 May;6(2):235–244. doi: 10.1099/00222615-6-2-235. [DOI] [PubMed] [Google Scholar]
  60. Perronne C. M., Malinverni R., Glauser M. P. Treatment of Staphylococcus aureus endocarditis in rats with coumermycin A1 and ciprofloxacin, alone or in combination. Antimicrob Agents Chemother. 1987 Apr;31(4):539–543. doi: 10.1128/aac.31.4.539. [DOI] [PMC free article] [PubMed] [Google Scholar]
  61. Putland R. A., Guinness M. D. Autobac susceptibility testing of methicillin-resistant Staphylococcus aureus isolated in an Australian hospital. J Clin Microbiol. 1985 Nov;22(5):822–827. doi: 10.1128/jcm.22.5.822-827.1985. [DOI] [PMC free article] [PubMed] [Google Scholar]
  62. Richmond A. S., Simberkoff M. S., Schaefler S., Rahal J. J., Jr Resistance of Staphylococcus aureus to semisynthetic penicillins and cephalothin. J Infect Dis. 1977 Jan;135(1):108–112. doi: 10.1093/infdis/135.1.108. [DOI] [PubMed] [Google Scholar]
  63. STEWART G. T., HOLT R. J. Evolutio of natural resistance to the newer penicillins. Br Med J. 1963 Feb 2;1(5326):308–311. doi: 10.1136/bmj.1.5326.308. [DOI] [PMC free article] [PubMed] [Google Scholar]
  64. SUTHERLAND R., ROLINSON G. N. CHARACTERISTICS OF METHICILLIN-RESISTANT STAPHYLOCOCCI. J Bacteriol. 1964 Apr;87:887–899. doi: 10.1128/jb.87.4.887-899.1964. [DOI] [PMC free article] [PubMed] [Google Scholar]
  65. Sabath L. D., Wallace S. J., Gerstein D. A. Suppression of intrinsic resistance to methicillin and other penicillins in Staphylococcus aureus. Antimicrob Agents Chemother. 1972 Nov;2(5):350–355. doi: 10.1128/aac.2.5.350. [DOI] [PMC free article] [PubMed] [Google Scholar]
  66. Sachdeva M., Hackbarth C., Stella F. B., Chambers H. F. Comparative activity of CGP 31608, nafcillin, cefamandole, imipenem, and vancomycin against methicillin-susceptible and methicillin-resistant staphylococci. Antimicrob Agents Chemother. 1987 Oct;31(10):1549–1552. doi: 10.1128/aac.31.10.1549. [DOI] [PMC free article] [PubMed] [Google Scholar]
  67. Sapico F. L., Montgomerie J. Z., Canawati H. N., Aeilts G. Methicillin-resistant Staphylococcus aureus bacteriuria. Am J Med Sci. 1981 Mar-Apr;281(2):101–109. doi: 10.1097/00000441-198103000-00004. [DOI] [PubMed] [Google Scholar]
  68. Schaefler S., Jones D., Perry W., Ruvinskaya L., Baradet T., Mayr E., Wilson M. E. Emergence of gentamicin- and methicillin-resistant Staphylococcus aureus strains in New York City hospitals. J Clin Microbiol. 1981 Apr;13(4):754–759. doi: 10.1128/jcm.13.4.754-759.1981. [DOI] [PMC free article] [PubMed] [Google Scholar]
  69. Schaefler S. Methicillin-resistant strains of Staphylococcus aureus resistant to quinolones. J Clin Microbiol. 1989 Feb;27(2):335–336. doi: 10.1128/jcm.27.2.335-336.1989. [DOI] [PMC free article] [PubMed] [Google Scholar]
  70. Schwalbe R. S., Stapleton J. T., Gilligan P. H. Emergence of vancomycin resistance in coagulase-negative staphylococci. N Engl J Med. 1987 Apr 9;316(15):927–931. doi: 10.1056/NEJM198704093161507. [DOI] [PubMed] [Google Scholar]
  71. Seligman S. J. In vitro susceptibility of methicillin-resistant Staphylococcus aureus to sulfamethoxazole and trimethoprim. J Infect Dis. 1973 Nov;128(Suppl):543–p. doi: 10.1093/infdis/128.supplement_3.s543. [DOI] [PubMed] [Google Scholar]
  72. Seligman S. J. Methicillin-resistant staphylococci: genetics of the minority population. J Gen Microbiol. 1966 Feb;42(2):315–322. doi: 10.1099/00221287-42-2-315. [DOI] [PubMed] [Google Scholar]
  73. Seligman S. J. Penicillinase-negative variants of methicillin-resistant Staphylococcus aureus. Nature. 1966 Mar 5;209(5027):994–996. doi: 10.1038/209994a0. [DOI] [PubMed] [Google Scholar]
  74. Smith S. M., Eng R. H., Tecson-Tumang F. Ciprofloxacin therapy for methicillin-resistant Staphylococcus aureus infections or colonizations. Antimicrob Agents Chemother. 1989 Feb;33(2):181–184. doi: 10.1128/aac.33.2.181. [DOI] [PMC free article] [PubMed] [Google Scholar]
  75. Sorrell T. C., Collignon P. J. A prospective study of adverse reactions associated with vancomycin therapy. J Antimicrob Chemother. 1985 Aug;16(2):235–241. doi: 10.1093/jac/16.2.235. [DOI] [PubMed] [Google Scholar]
  76. Sorrell T. C., Packham D. R., Shanker S., Foldes M., Munro R. Vancomycin therapy for methicillin-resistant Staphylococcus aureus. Ann Intern Med. 1982 Sep;97(3):344–350. doi: 10.7326/0003-4819-97-3-344. [DOI] [PubMed] [Google Scholar]
  77. Sullam P. M., Täuber M. G., Hackbarth C. J., Chambers H. F., Scott K. G., Sande M. A. Pefloxacin therapy for experimental endocarditis caused by methicillin-susceptible or methicillin-resistant strains of Staphylococcus aureus. Antimicrob Agents Chemother. 1985 May;27(5):685–687. doi: 10.1128/aac.27.5.685. [DOI] [PMC free article] [PubMed] [Google Scholar]
  78. Thornsberry C., McDougal L. K. Successful use of broth microdilution in susceptibility tests for methicillin-resistant (heteroresistant) staphylococci. J Clin Microbiol. 1983 Nov;18(5):1084–1091. doi: 10.1128/jcm.18.5.1084-1091.1983. [DOI] [PMC free article] [PubMed] [Google Scholar]
  79. Vazquez G. J., Archer G. L. Antibiotic therapy of experimental Staphylococcus epidermidis endocarditis. Antimicrob Agents Chemother. 1980 Feb;17(2):280–285. doi: 10.1128/aac.17.2.280. [DOI] [PMC free article] [PubMed] [Google Scholar]
  80. Walsh T. J., Hansen S. L., Tatem B. A., Auger F., Standiford H. C. Activity of novobiocin against methicillin-resistant Staphylococcus aureus. J Antimicrob Chemother. 1985 Apr;15(4):435–440. doi: 10.1093/jac/15.4.435. [DOI] [PubMed] [Google Scholar]
  81. Ward T. T., Winn R. E., Hartstein A. I., Sewell D. L. Observations relating to an inter-hospital outbreak of methicillin-resistant Staphylococcus aureus: role of antimicrobial therapy in infection control. Infect Control. 1981 Nov-Dec;2(6):453–459. doi: 10.1017/s0195941700055715. [DOI] [PubMed] [Google Scholar]
  82. Watanakunakorn C. Effect of inoculum size on in vitro susceptibility of methicillin-resistant Staphylococcus aureus to eighteen antimicrobial agents. Eur J Clin Microbiol. 1985 Feb;4(1):68–70. doi: 10.1007/BF02148668. [DOI] [PubMed] [Google Scholar]
  83. Watanakunakorn C., Guerriero J. C. Interaction between vancomycin and rifampin against Staphylococcus aureus. Antimicrob Agents Chemother. 1981 Jun;19(6):1089–1091. doi: 10.1128/aac.19.6.1089. [DOI] [PMC free article] [PubMed] [Google Scholar]
  84. Watanakunakorn C., Tisone J. C. Synergism between vancomycin and gentamicin or tobramycin for methicillin-susceptible and methicillin-resistant Staphylococcus aureus strains. Antimicrob Agents Chemother. 1982 Nov;22(5):903–905. doi: 10.1128/aac.22.5.903. [DOI] [PMC free article] [PubMed] [Google Scholar]
  85. Watanakunakorn C. Treatment of infections due to methicillin-resistant Staphylococcus aureus. Ann Intern Med. 1982 Sep;97(3):376–378. doi: 10.7326/0003-4819-97-3-376. [DOI] [PubMed] [Google Scholar]
  86. Woods G. L., Hall G. S., Rutherford I., Pratt K. J., Knapp C. C. Detection of methicillin-resistant Staphylococcus epidermidis. J Clin Microbiol. 1986 Sep;24(3):349–352. doi: 10.1128/jcm.24.3.349-352.1986. [DOI] [PMC free article] [PubMed] [Google Scholar]
  87. Woolfrey B. F., Lally R. T., Ederer M. N. Evaluation of the AutoMicrobic system Gram-Positive Susceptibility-MIC card for detection of oxacillin-resistant coagulase-negative staphylococci. J Clin Microbiol. 1986 Mar;23(3):629–630. doi: 10.1128/jcm.23.3.629-630.1986. [DOI] [PMC free article] [PubMed] [Google Scholar]
  88. de Rautlin de la Roy Y., Chevalier-Burbaud E., Pannetier S., Souchaud F. Use of the Autobac system for detection of methicillin-resistant Staphylococcus aureus. J Clin Microbiol. 1985 Sep;22(3):467–469. doi: 10.1128/jcm.22.3.467-469.1985. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES